A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

Clinical trial NCT04864977 · WITHDRAWN

Trial details

NCT number: NCT04864977
Sponsor: Eli Lilly and Company
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Type 2 Diabetes Treated With Insulin

Start date: 2021-08-16
Primary completion: 2022-06-06
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.